 | • レポートコード：B-GIR08C4955 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、リボシクリブの世界市場について調べ、まとめました。種類別セグメントは、21テーブル/箱、42テーブル/箱、63テーブル/箱等、用途別セグメントは、電源トランス、トランスミッション＆ディストリビュータートランス、その他等に区分しました。リボシクリブの世界市場概観、企業動向、企業別リボシクリブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・リボシクリブの市場概観 ・リボシクリブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・リボシクリブの企業別販売動向、市場シェア、市場集中度、競争動向 ・リボシクリブの世界市場規模 ・リボシクリブの北米市場分析（アメリカ、カナダ、メキシコ等） ・リボシクリブのアメリカ市場規模推移 ・リボシクリブのカナダ市場規模推移 ・リボシクリブのメキシコ市場規模推移 ・リボシクリブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・リボシクリブのドイツ市場規模推移 ・リボシクリブのイギリス市場規模推移 ・リボシクリブのロシア市場規模推移 ・リボシクリブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・リボシクリブの日本市場規模推移 ・リボシクリブの中国市場規模推移 ・リボシクリブの韓国市場規模推移 ・リボシクリブのインド市場規模推移 ・リボシクリブの東南アジア市場規模推移 ・リボシクリブの南米市場分析（ブラジル、アルゼンチン等） ・リボシクリブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・リボシクリブの種類別分析/販売量、売上、市場シェア（21テーブル/箱、42テーブル/箱、63テーブル/箱） ・リボシクリブの用途別分析/市場規模（電源トランス、トランスミッション＆ディストリビュータートランス、その他） ・リボシクリブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・リボシクリブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Ribociclib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Ribociclib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Novartis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
21 Tables/Box
42 Tables/Box
63 Tables/Box
Market Segment by Applications, can be divided into
Hospital
Drug Center
Clinic
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ribociclib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ribociclib, with price, sales, revenue and global market share of Ribociclib in 2017 and 2018.
Chapter 3, the Ribociclib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ribociclib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Ribociclib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Ribociclib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Ribociclib Introduction
1.2 Market Analysis by Type
1.2.1 21 Tables/Box
1.2.2 42 Tables/Box
1.2.3 63 Tables/Box
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Drug Center
1.3.3 Clinic
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Ribociclib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Ribociclib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Ribociclib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Ribociclib Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Ribociclib Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Ribociclib Manufacturer Market Share in 2018
3.3.2 Top 6 Ribociclib Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Ribociclib Market Analysis by Regions
4.1 Global Ribociclib Sales, Revenue and Market Share by Regions
4.1.1 Global Ribociclib Sales and Market Share by Regions (2014-2019)
4.1.2 Global Ribociclib Revenue and Market Share by Regions (2014-2019)
4.2 North America Ribociclib Sales and Growth Rate (2014-2019)
4.3 Europe Ribociclib Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Ribociclib Sales and Growth Rate (2014-2019)
4.5 South America Ribociclib Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Ribociclib Sales and Growth Rate (2014-2019)
5 North America Ribociclib by Country
5.1 North America Ribociclib Sales, Revenue and Market Share by Country
5.1.1 North America Ribociclib Sales and Market Share by Country (2014-2019)
5.1.2 North America Ribociclib Revenue and Market Share by Country (2014-2019)
5.2 United States Ribociclib Sales and Growth Rate (2014-2019)
5.3 Canada Ribociclib Sales and Growth Rate (2014-2019)
5.4 Mexico Ribociclib Sales and Growth Rate (2014-2019)
6 Europe Ribociclib by Country
6.1 Europe Ribociclib Sales, Revenue and Market Share by Country
6.1.1 Europe Ribociclib Sales and Market Share by Country (2014-2019)
6.1.2 Europe Ribociclib Revenue and Market Share by Country (2014-2019)
6.2 Germany Ribociclib Sales and Growth Rate (2014-2019)
6.3 UK Ribociclib Sales and Growth Rate (2014-2019)
6.4 France Ribociclib Sales and Growth Rate (2014-2019)
6.5 Russia Ribociclib Sales and Growth Rate (2014-2019)
6.6 Italy Ribociclib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Ribociclib by Country
7.1 Asia-Pacific Ribociclib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Ribociclib Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Ribociclib Revenue and Market Share by Country (2014-2019)
7.2 China Ribociclib Sales and Growth Rate (2014-2019)
7.3 Japan Ribociclib Sales and Growth Rate (2014-2019)
7.4 Korea Ribociclib Sales and Growth Rate (2014-2019)
7.5 India Ribociclib Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Ribociclib Sales and Growth Rate (2014-2019)
8 South America Ribociclib by Country
8.1 South America Ribociclib Sales, Revenue and Market Share by Country
8.1.1 South America Ribociclib Sales and Market Share by Country (2014-2019)
8.1.2 South America Ribociclib Revenue and Market Share by Country (2014-2019)
8.2 Brazil Ribociclib Sales and Growth Rate (2014-2019)
8.3 Argentina Ribociclib Sales and Growth Rate (2014-2019)
8.4 Colombia Ribociclib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Ribociclib by Countries
9.1 Middle East and Africa Ribociclib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Ribociclib Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Ribociclib Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Ribociclib Sales and Growth Rate (2014-2019)
9.3 Turkey Ribociclib Sales and Growth Rate (2014-2019)
9.4 Egypt Ribociclib Sales and Growth Rate (2014-2019)
9.5 Nigeria Ribociclib Sales and Growth Rate (2014-2019)
9.6 South Africa Ribociclib Sales and Growth Rate (2014-2019)
10 Global Ribociclib Market Segment by Type
10.1 Global Ribociclib Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Ribociclib Sales and Market Share by Type (2014-2019)
10.1.2 Global Ribociclib Revenue and Market Share by Type (2014-2019)
10.2 21 Tables/Box Sales Growth and Price
10.2.1 Global 21 Tables/Box Sales Growth (2014-2019)
10.2.2 Global 21 Tables/Box Price (2014-2019)
10.3 42 Tables/Box Sales Growth and Price
10.3.1 Global 42 Tables/Box Sales Growth (2014-2019)
10.3.2 Global 42 Tables/Box Price (2014-2019)
10.4 63 Tables/Box Sales Growth and Price
10.4.1 Global 63 Tables/Box Sales Growth (2014-2019)
10.4.2 Global 63 Tables/Box Price (2014-2019)
11 Global Ribociclib Market Segment by Application
11.1 Global Ribociclib Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Drug Center Sales Growth (2014-2019)
11.4 Clinic Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Ribociclib Market Forecast (2019-2024)
12.1 Global Ribociclib Sales, Revenue and Growth Rate (2019-2024)
12.2 Ribociclib Market Forecast by Regions (2019-2024)
12.2.1 North America Ribociclib Market Forecast (2019-2024)
12.2.2 Europe Ribociclib Market Forecast (2019-2024)
12.2.3 Asia-Pacific Ribociclib Market Forecast (2019-2024)
12.2.4 South America Ribociclib Market Forecast (2019-2024)
12.2.5 Middle East and Africa Ribociclib Market Forecast (2019-2024)
12.3 Ribociclib Market Forecast by Type (2019-2024)
12.3.1 Global Ribociclib Sales Forecast by Type (2019-2024)
12.3.2 Global Ribociclib Market Share Forecast by Type (2019-2024)
12.4 Ribociclib Market Forecast by Application (2019-2024)
12.4.1 Global Ribociclib Sales Forecast by Application (2019-2024)
12.4.2 Global Ribociclib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Ribociclib Picture
Table Product Specifications of Ribociclib
Figure Global Sales Market Share of Ribociclib by Types in 2018
Table Ribociclib Types for Major Manufacturers
Figure 21 Tables/Box Picture
Figure 42 Tables/Box Picture
Figure 63 Tables/Box Picture
Figure Ribociclib Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Drug Center Picture
Figure Clinic Picture
Figure Other Picture
Figure United States Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure France Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure UK Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure China Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure India Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Ribociclib Revenue (Value) and Growth Rate (2014-2024)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Ribociclib Type and Applications
Table Novartis Ribociclib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Ribociclib Sales by Manufacturer (2017-2018)
Figure Global Ribociclib Sales Market Share by Manufacturer in 2017
Figure Global Ribociclib Sales Market Share by Manufacturer in 2018
Table Global Ribociclib Revenue by Manufacturer (2017-2018)
Figure Global Ribociclib Revenue Market Share by Manufacturer in 2017
Figure Global Ribociclib Revenue Market Share by Manufacturer in 2018
Figure Top 3 Ribociclib Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Ribociclib Manufacturer (Revenue) Market Share in 2018
Figure Global Ribociclib Sales and Growth Rate (2014-2019)
Figure Global Ribociclib Revenue and Growth Rate (2014-2019)
Table Global Ribociclib Sales by Regions (2014-2019)
Table Global Ribociclib Sales Market Share by Regions (2014-2019)
Table Global Ribociclib Revenue by Regions (2014-2019)
Figure Global Ribociclib Revenue Market Share by Regions (2014-2019)
Figure Global Ribociclib Revenue Market Share by Regions in 2018
Figure North America Ribociclib Sales and Growth Rate (2014-2019)
Figure Europe Ribociclib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Ribociclib Sales and Growth Rate (2014-2019)
Figure South America Ribociclib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Ribociclib Sales and Growth Rate (2014-2019)
Figure North America Ribociclib Revenue and Growth Rate (2014-2019)
Table North America Ribociclib Sales by Countries (2014-2019)
Table North America Ribociclib Sales Market Share by Countries (2014-2019)
Figure North America Ribociclib Sales Market Share by Countries (2014-2019)
Figure North America Ribociclib Sales Market Share by Countries in 2018
Table North America Ribociclib Revenue by Countries (2014-2019)
Table North America Ribociclib Revenue Market Share by Countries (2014-2019)
Figure North America Ribociclib Revenue Market Share by Countries (2014-2019)
Figure North America Ribociclib Revenue Market Share by Countries in 2018
Figure United States Ribociclib Sales and Growth Rate (2014-2019)
Figure Canada Ribociclib Sales and Growth Rate (2014-2019)
Figure Mexico Ribociclib Sales and Growth Rate (2014-2019)
Figure Europe Ribociclib Revenue and Growth Rate (2014-2019)
Table Europe Ribociclib Sales by Countries (2014-2019)
Table Europe Ribociclib Sales Market Share by Countries (2014-2019)
Table Europe Ribociclib Revenue by Countries (2014-2019)
Figure Europe Ribociclib Revenue Market Share by Countries (2014-2019)
Figure Europe Ribociclib Revenue Market Share by Countries in 2018
Figure Germany Ribociclib Sales and Growth Rate (2014-2019)
Figure UK Ribociclib Sales and Growth Rate (2014-2019)
Figure France Ribociclib Sales and Growth Rate (2014-2019)
Figure Russia Ribociclib Sales and Growth Rate (2014-2019)
Figure Italy Ribociclib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Ribociclib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Ribociclib Sales by Countries (2014-2019)
Table Asia-Pacific Ribociclib Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Ribociclib Sales Market Share by Countries 2018
Table Asia-Pacific Ribociclib Revenue by Countries (2014-2019)
Figure Asia-Pacific Ribociclib Revenue Market Share by Countries 2018
Figure China Ribociclib Sales and Growth Rate (2014-2019)
Figure Japan Ribociclib Sales and Growth Rate (2014-2019)
Figure Korea Ribociclib Sales and Growth Rate (2014-2019)
Figure India Ribociclib Sales and Growth Rate (2014-2019)
Figure Southeast Asia Ribociclib Sales and Growth Rate (2014-2019)
Figure South America Ribociclib Revenue and Growth Rate (2014-2019)
Table South America Ribociclib Sales by Countries (2014-2019)
Table South America Ribociclib Sales Market Share by Countries (2014-2019)
Figure South America Ribociclib Sales Market Share by Countries in 2018
Table South America Ribociclib Revenue by Countries (2014-2019)
Table South America Ribociclib Revenue Market Share by Countries (2014-2019)
Figure South America Ribociclib Revenue Market Share by Countries in 2018
Figure Brazil Ribociclib Sales and Growth Rate (2014-2019)
Figure Argentina Ribociclib Sales and Growth Rate (2014-2019)
Figure Colombia Ribociclib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Ribociclib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Ribociclib Sales by Countries (2014-2019)
Table Middle East and Africa Ribociclib Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Ribociclib Sales Market Share by Countries in 2018
Table Middle East and Africa Ribociclib Revenue by Countries (2014-2019)
Table Middle East and Africa Ribociclib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Ribociclib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Ribociclib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Ribociclib Sales and Growth Rate (2014-2019)
Figure UAE Ribociclib Sales and Growth Rate (2014-2019)
Figure Egypt Ribociclib Sales and Growth Rate (2014-2019)
Figure Nigeria Ribociclib Sales and Growth Rate (2014-2019)
Figure South Africa Ribociclib Sales and Growth Rate (2014-2019)
Table Global Ribociclib Sales by Type (2014-2019)
Table Global Ribociclib Sales Share by Type (2014-2019)
Table Global Ribociclib Revenue by Type (2014-2019)
Table Global Ribociclib Revenue Share by Type (2014-2019)
Figure Global 21 Tables/Box Sales Growth (2014-2019)
Figure Global 21 Tables/Box Price (2014-2019)
Figure Global 42 Tables/Box Sales Growth (2014-2019)
Figure Global 42 Tables/Box Price (2014-2019)
Figure Global 63 Tables/Box Sales Growth (2014-2019)
Figure Global 63 Tables/Box Price (2014-2019)
Table Global Ribociclib Sales by Application (2014-2019)
Table Global Ribociclib Sales Share by Application (2014-2019)
Figure Global Drug Center Sales Growth (2014-2019)
Figure Global Clinic Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Ribociclib Sales, Revenue and Growth Rate (2019-2024)
Table Global Ribociclib Sales Forecast by Regions (2019-2024)
Table Global Ribociclib Market Share Forecast by Regions (2019-2024)
Figure North America Sales Ribociclib Market Forecast (2019-2024)
Figure Europe Sales Ribociclib Market Forecast (2019-2024)
Figure Asia-Pacific Sales Ribociclib Market Forecast (2019-2024)
Figure South America Sales Ribociclib Market Forecast (2019-2024)
Figure Middle East and Africa Sales Ribociclib Market Forecast (2019-2024)
Table Global Ribociclib Sales Forecast by Type (2019-2024)
Table Global Ribociclib Market Share Forecast by Type (2019-2024)
Table Global Ribociclib Sales Forecast by Application (2019-2024)
Table Global Ribociclib Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
ドルテグラビル/リルピビリン配合薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Dolutegravir/Rilpivirine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on t…- ドルテグラビル及び併用薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Dolutegravir and Its Combination Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especial…
- 乳がんCDK4 / 6阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global CDK4/6 Inhibitors for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…
- エファビレンツ/テノホビル/エムトリシタビン配合薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Efavirenz/Tenofovir/Emtricitabine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report foc…
- 甲状腺ホルモン障害薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Thyroid Hormone Disorder Drug is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Thyroid Hormone Dis…